SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Gajewski Kristen

(Last)

(First)

(Middle)

AVIENT CENTER

(Street)

AVON LAKE

44012

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/01/2023

3. Issuer Name and Ticker or Trading Symbol
AVIENT CORP [ AVNT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP & CHRO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	929	D
Common Stock	840.407	I	Savings Plan Trust⁽¹⁾
Common Stock	95.234	I	Supplemental Plan⁽¹⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Stock Units	⁽²⁾	02/10/2023	Common Stock	769⁽³⁾	⁽²⁾	D
Restricted Stock Units	⁽⁴⁾	02/08/2024	Common Stock	670⁽³⁾	⁽⁴⁾	D
Restricted Stock Units	⁽⁵⁾	02/14/2025	Common Stock	668⁽³⁾	⁽⁵⁾	D
Stock Appreciation Rights	⁽⁶⁾	02/14/2028	Common Stock	1,150	$41.89	D
Stock Appreciation Rights	⁽⁷⁾	02/11/2029	Common Stock	700	$31.54	D
Stock Appreciation Rights	⁽⁸⁾	02/10/2030	Common Stock	1,466	$31.48	D
Stock Appreciation Rights	⁽⁹⁾	02/08/2031	Common Stock	2,570	$42.27	D
Stock Appreciation Rights	⁽¹⁰⁾	02/11/2032	Common Stock	2,300	$52.64	D

Explanation of Responses:

1. The information in this report is based on a plan statement as of February 1, 2023.

2. The restricted stock units vest 3 years from the date of grant on February 10, 2023.

3. The restricted stock units include all dividend equivalents acquired since the date of grant. Dividend equivalents are subject to the same restrictions as the underlying grant of restricted stock units.

4. The restricted stock units vest 3 years from the date of grant on February 8, 2024.

5. The restricted stock units vest 3 years from the date of grant on February 14, 2025.

6. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $41.89 per share and no more than one-third of the grant can vest per year during the first three years.

7. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.54 per share and no more than one-third of the grant can vest per year during the first three years.

8. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.48 per share and no more than one-third of the grant can vest per year during the first three years.

9. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $42.27 per share and no more than one-third of the grant can vest per year during the first three years.

10. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $52.64 per share and no more than one-third of the grant can vest per year during the first three years.

	/s/ Lisa K. Kunkle, Power of Attorney For: Kristen Gajewski	02/08/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.